Department of Family and Community Medicine, Women's College Hospital, Toronto, Ontario, Canada.
Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
JAMA Netw Open. 2022 Sep 1;5(9):e2233659. doi: 10.1001/jamanetworkopen.2022.33659.
People with opioid use disorder are less likely than others to have a primary care physician.
To determine if family physicians are less likely to accept people with opioid use disorder as new patients than people with diabetes.
DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial used an audit design to survey new patient intake at randomly selected family physicians in Ontario, Canada. Eligible physicians were independent practitioners allowed to prescribe opioids who were located in an office within 50 km of a population center greater than 20 000 people. A patient actor made unannounced telephone calls to family physicians asking for a new patient appointment. The data were analyzed in September 2021.
In the first randomly assigned scenario, the patient actor played a role of patient with diabetes in treatment with an endocrinologist. In the second scenario, the patient actor played a role of a patient with opioid use disorder undergoing methadone treatment with an addiction physician.
Total offers of a new patient appointment; a secondary analysis compared the proportions of patients offered an appointment stratified by gender, population, model of care, and years in practice.
Of a total 383 family physicians included in analysis, a greater proportion offered a new patient appointment to a patient with diabetes (21 of 185 physicians [11.4%]) than with opioid use disorder (8 of 198 physicians [4.0%]) (absolute difference, 7.4%; 95% CI, 2.0 to 12.6; P = .007). Physicians with more than 20 years in practice were almost 13 times less likely to offer an appointment to a patient with opioid use disorder compared with diabetes (1 of 108 physicians [0.9%] vs 10 of 84 physicians [11.9%]; absolute difference, 11.0; 95% CI, 3.8 to 18.1; P = .001). Women were almost 5 times less likely (3 of 111 physicians [2.7%] vs 14 of 114 physicians [12.3%]; absolute difference, 9.6%; 95% CI, 2.4 to 16.3; P = .007) to offer an appointment to a patient with opioid use disorder than with diabetes.
In this randomized clinical trial, family physicians were less likely to offer a new patient appointment to a patient with opioid use disorder compared with a patient with diabetes. Potential health system solutions to this disparity include strengthening policies for accepting new patients, improved compensation, and clinician anti-oppression training.
ClinicalTrials.gov Identifier: NCT05484609.
与其他人相比,患有阿片类药物使用障碍的人更不可能有初级保健医生。
确定家庭医生是否比接受阿片类药物使用障碍的患者更不愿意接受患有糖尿病的患者作为新患者。
设计、地点和参与者:这项随机临床试验采用审计设计,在加拿大安大略省随机选择的家庭医生处调查新患者的摄入量。合格的医生是独立从业者,允许开具阿片类药物,他们位于人口中心 20000 人以上的 50 公里内的办公室。患者演员通过电话向家庭医生预约新患者。数据分析于 2021 年 9 月进行。
在第一个随机分配的场景中,患者扮演者扮演一名正在接受内分泌学家治疗的糖尿病患者。在第二个场景中,患者扮演者扮演一名正在接受成瘾医生美沙酮治疗的阿片类药物使用障碍患者。
新患者预约的总提供情况;一项次要分析比较了按性别、人口、护理模式和从业年限分层的患者提供预约的比例。
在总共纳入分析的 383 名家庭医生中,与患有阿片类药物使用障碍的患者(198 名医生中的 8 名[4.0%])相比,更多的医生为患有糖尿病的患者(185 名医生中的 21 名[11.4%])提供了新患者预约(绝对差异,7.4%;95%CI,2.0 至 12.6;P=.007)。从业超过 20 年的医生接受阿片类药物使用障碍患者预约的可能性几乎低 13 倍,而不是糖尿病患者(108 名医生中的 1 名[0.9%]与 84 名医生中的 10 名[11.9%];绝对差异,11.0;95%CI,3.8 至 18.1;P=.001)。与患有糖尿病的患者相比,女性(111 名医生中的 3 名[2.7%]与 114 名医生中的 14 名[12.3%])接受阿片类药物使用障碍患者预约的可能性几乎低 5 倍(绝对差异,9.6%;95%CI,2.4 至 16.3;P=.007)。
在这项随机临床试验中,家庭医生为阿片类药物使用障碍患者提供新患者预约的可能性低于糖尿病患者。解决这种差异的潜在卫生系统解决方案包括加强接受新患者的政策、提高补偿和临床医生反压迫培训。
ClinicalTrials.gov 标识符:NCT05484609。